In clear cell renal cell carcinoma (ccRCC), METTL14 expression is inversely correlated with Treg abundance and positively associated with CCL5 levels, suggesting a METTL14/CCL5/Tregs axis that shapes the tumor immune landscape (34). The gene discussed is CCL5; the disease is neoplasm.